AE Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Buy |
|
|||||
|
2025
Q1 | $826K | Buy |
|
|||||
|
2024
Q4 | $676K | Buy |
|
|||||
|
2024
Q3 | $808K | Sell |
|
|||||
|
2024
Q2 | $765K | Buy |
|
|||||
|
2024
Q1 | $817K | Sell |
|
|||||
|
2023
Q4 | $2M | Buy |
|
|||||
|
2023
Q3 | $1.56M | Sell |
|
|||||
|
2023
Q2 | $1.54M | Sell |
|
|||||
|
2023
Q1 | $3.84M | Buy |
|
|||||
|
2022
Q4 | $3.51M | Buy |
|
|||||
|
2022
Q3 | $2.88M | Buy |
|
|||||
|
2022
Q2 | $5.01M | Buy |
|
|||||
|
2022
Q1 | $3.88M | Sell |
|
|||||
|
2021
Q4 | $3.93M | Buy |
|
|||||
|
2021
Q3 | $3.21M | Buy |
|
|||||
|
2021
Q2 | $2.59M | Buy |
|
|||||
|
2021
Q1 | $1.27M | Sell |
|
|||||
|
2020
Q4 | $2.9M | Sell |
|
|||||
|
2020
Q3 | $3.55M | Sell |
|
|||||
|
2020
Q2 | $3.91M | Buy |
|
|||||
|
2020
Q1 | $3.16M | Sell |
|
|||||
|
2019
Q4 | $4.12M | Buy |
|
|||||
|
2019
Q3 | $3.29M | Sell |
|
|||||
|
2019
Q2 | $3.79M | Buy |
|
|||||
|
2019
Q1 | $1.9M | Buy |
|
|||||
|
2018
Q4 | $1.52M | Sell |
|
|||||
|
2018
Q3 | $2.45M | Buy |
|
|||||
|
2018
Q2 | $1.24M | Buy |
|
|||||
|
2018
Q1 | $1.02M | Buy |
|
|||||
|
2017
Q4 | $849K | Sell |
|
|||||
|
2017
Q3 | $1.23M | Sell |
|
|||||
|
2017
Q2 | $1.38M | Buy |
|
|||||
|
2017
Q1 | $809K | Buy |
|
|||||
|
2016
Q4 | $556K | Buy |
|